Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Pulmonary Drugs market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Pulmonary Drugs are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Pulmonary Drugs market segmented into
Inhaled Corticosteroids (ICS)
Long-Acting Beta2-Agonists (LABA)
Antihistamine
Vasodilators
Short-Acting Beta2-Agonists (SABA)
Anticholinergics
Combination Drugs
MAbs
Enzymes
Antibiotics & Antileukotrienes
Based on the end-use, the global Pulmonary Drugs market classified into
Asthma & COPD
Allergic Rhinitis
Pulmonary Arterial Hypertension
Cystic Fibrosis
Based on geography, the global Pulmonary Drugs market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
AstraZeneca plc
Bayer AG
Teva Pharmaceutical Industries Ltd
Actelion Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Novartis AG
GlaxoSmithKline plc
Sunovion Pharmaceuticals
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PULMONARY DRUGS INDUSTRY
2.1 Summary about Pulmonary Drugs Industry
2.2 Pulmonary Drugs Market Trends
2.2.1 Pulmonary Drugs Production & Consumption Trends
2.2.2 Pulmonary Drugs Demand Structure Trends
2.3 Pulmonary Drugs Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Inhaled Corticosteroids (ICS)
4.2.2 Long-Acting Beta2-Agonists (LABA)
4.2.3 Antihistamine
4.2.4 Vasodilators
4.2.5 Short-Acting Beta2-Agonists (SABA)
4.2.6 Anticholinergics
4.2.7 Combination Drugs
4.2.8 MAbs
4.2.9 Enzymes
4.2.10 Antibiotics & Antileukotrienes
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Asthma & COPD
4.3.2 Allergic Rhinitis
4.3.3 Pulmonary Arterial Hypertension
4.3.4 Cystic Fibrosis
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Inhaled Corticosteroids (ICS)
5.2.2 Long-Acting Beta2-Agonists (LABA)
5.2.3 Antihistamine
5.2.4 Vasodilators
5.2.5 Short-Acting Beta2-Agonists (SABA)
5.2.6 Anticholinergics
5.2.7 Combination Drugs
5.2.8 MAbs
5.2.9 Enzymes
5.2.10 Antibiotics & Antileukotrienes
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Asthma & COPD
5.3.2 Allergic Rhinitis
5.3.3 Pulmonary Arterial Hypertension
5.3.4 Cystic Fibrosis
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Inhaled Corticosteroids (ICS)
6.2.2 Long-Acting Beta2-Agonists (LABA)
6.2.3 Antihistamine
6.2.4 Vasodilators
6.2.5 Short-Acting Beta2-Agonists (SABA)
6.2.6 Anticholinergics
6.2.7 Combination Drugs
6.2.8 MAbs
6.2.9 Enzymes
6.2.10 Antibiotics & Antileukotrienes
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Asthma & COPD
6.3.2 Allergic Rhinitis
6.3.3 Pulmonary Arterial Hypertension
6.3.4 Cystic Fibrosis
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Inhaled Corticosteroids (ICS)
7.2.2 Long-Acting Beta2-Agonists (LABA)
7.2.3 Antihistamine
7.2.4 Vasodilators
7.2.5 Short-Acting Beta2-Agonists (SABA)
7.2.6 Anticholinergics
7.2.7 Combination Drugs
7.2.8 MAbs
7.2.9 Enzymes
7.2.10 Antibiotics & Antileukotrienes
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Asthma & COPD
7.3.2 Allergic Rhinitis
7.3.3 Pulmonary Arterial Hypertension
7.3.4 Cystic Fibrosis
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Inhaled Corticosteroids (ICS)
8.2.2 Long-Acting Beta2-Agonists (LABA)
8.2.3 Antihistamine
8.2.4 Vasodilators
8.2.5 Short-Acting Beta2-Agonists (SABA)
8.2.6 Anticholinergics
8.2.7 Combination Drugs
8.2.8 MAbs
8.2.9 Enzymes
8.2.10 Antibiotics & Antileukotrienes
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Asthma & COPD
8.3.2 Allergic Rhinitis
8.3.3 Pulmonary Arterial Hypertension
8.3.4 Cystic Fibrosis
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Inhaled Corticosteroids (ICS)
9.2.2 Long-Acting Beta2-Agonists (LABA)
9.2.3 Antihistamine
9.2.4 Vasodilators
9.2.5 Short-Acting Beta2-Agonists (SABA)
9.2.6 Anticholinergics
9.2.7 Combination Drugs
9.2.8 MAbs
9.2.9 Enzymes
9.2.10 Antibiotics & Antileukotrienes
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Asthma & COPD
9.3.2 Allergic Rhinitis
9.3.3 Pulmonary Arterial Hypertension
9.3.4 Cystic Fibrosis
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 AstraZeneca plc
10.1.2 Bayer AG
10.1.3 Teva Pharmaceutical Industries Ltd
10.1.4 Actelion Pharmaceuticals, Inc.
10.1.5 Boehringer Ingelheim GmbH
10.1.6 F. Hoffmann-La Roche Ltd.
10.1.7 Merck & Co., Inc.
10.1.8 Novartis AG
10.1.9 GlaxoSmithKline plc
10.1.10 Sunovion Pharmaceuticals
10.2 Pulmonary Drugs Sales Date of Major Players (2017-2020e)
10.2.1 AstraZeneca plc
10.2.2 Bayer AG
10.2.3 Teva Pharmaceutical Industries Ltd
10.2.4 Actelion Pharmaceuticals, Inc.
10.2.5 Boehringer Ingelheim GmbH
10.2.6 F. Hoffmann-La Roche Ltd.
10.2.7 Merck & Co., Inc.
10.2.8 Novartis AG
10.2.9 GlaxoSmithKline plc
10.2.10 Sunovion Pharmaceuticals
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Table
Table Pulmonary Drugs Product Type Overview
Table Pulmonary Drugs Product Type Market Share List
Table Pulmonary Drugs Product Type of Major Players
Table Brief Introduction of AstraZeneca plc
Table Brief Introduction of Bayer AG
Table Brief Introduction of Teva Pharmaceutical Industries Ltd
Table Brief Introduction of Actelion Pharmaceuticals, Inc.
Table Brief Introduction of Boehringer Ingelheim GmbH
Table Brief Introduction of F. Hoffmann-La Roche Ltd.
Table Brief Introduction of Merck & Co., Inc.
Table Brief Introduction of Novartis AG
Table Brief Introduction of GlaxoSmithKline plc
Table Brief Introduction of Sunovion Pharmaceuticals
Table Products & Services of AstraZeneca plc
Table Products & Services of Bayer AG
Table Products & Services of Teva Pharmaceutical Industries Ltd
Table Products & Services of Actelion Pharmaceuticals, Inc.
Table Products & Services of Boehringer Ingelheim GmbH
Table Products & Services of F. Hoffmann-La Roche Ltd.
Table Products & Services of Merck & Co., Inc.
Table Products & Services of Novartis AG
Table Products & Services of GlaxoSmithKline plc
Table Products & Services of Sunovion Pharmaceuticals
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Pulmonary Drugs Market Forecast (Million USD) by Region 2021f-2026f
Table Global Pulmonary Drugs Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Pulmonary Drugs Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Pulmonary Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Pulmonary Drugs Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Pulmonary Drugs Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Pulmonary Drugs Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Pulmonary Drugs Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Pulmonary Drugs Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Pulmonary Drugs Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Pulmonary Drugs Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Inhaled Corticosteroids (ICS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-Acting Beta2-Agonists (LABA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antihistamine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Vasodilators Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Short-Acting Beta2-Agonists (SABA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Anticholinergics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Combination Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MAbs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Enzymes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antibiotics & Antileukotrienes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asthma & COPD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Allergic Rhinitis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pulmonary Arterial Hypertension Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cystic Fibrosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Inhaled Corticosteroids (ICS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-Acting Beta2-Agonists (LABA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antihistamine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Vasodilators Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Short-Acting Beta2-Agonists (SABA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Anticholinergics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Combination Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MAbs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Enzymes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antibiotics & Antileukotrienes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asthma & COPD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Allergic Rhinitis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pulmonary Arterial Hypertension Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cystic Fibrosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Inhaled Corticosteroids (ICS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-Acting Beta2-Agonists (LABA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antihistamine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Vasodilators Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Short-Acting Beta2-Agonists (SABA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Anticholinergics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Combination Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MAbs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Enzymes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antibiotics & Antileukotrienes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asthma & COPD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Allergic Rhinitis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pulmonary Arterial Hypertension Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cystic Fibrosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Inhaled Corticosteroids (ICS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-Acting Beta2-Agonists (LABA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antihistamine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Vasodilators Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Short-Acting Beta2-Agonists (SABA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Anticholinergics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Combination Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MAbs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Enzymes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antibiotics & Antileukotrienes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asthma & COPD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Allergic Rhinitis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pulmonary Arterial Hypertension Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cystic Fibrosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Inhaled Corticosteroids (ICS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-Acting Beta2-Agonists (LABA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antihistamine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Vasodilators Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Short-Acting Beta2-Agonists (SABA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Anticholinergics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Combination Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MAbs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Enzymes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antibiotics & Antileukotrienes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asthma & COPD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Allergic Rhinitis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pulmonary Arterial Hypertension Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cystic Fibrosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Inhaled Corticosteroids (ICS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-Acting Beta2-Agonists (LABA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antihistamine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Vasodilators Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Short-Acting Beta2-Agonists (SABA) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Anticholinergics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Combination Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MAbs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Enzymes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antibiotics & Antileukotrienes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asthma & COPD Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Allergic Rhinitis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pulmonary Arterial Hypertension Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cystic Fibrosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pulmonary Drugs Sales Revenue (Million USD) of AstraZeneca plc 2017-2020e
Figure Pulmonary Drugs Sales Revenue (Million USD) of Bayer AG 2017-2020e
Figure Pulmonary Drugs Sales Revenue (Million USD) of Teva Pharmaceutical Industries Ltd 2017-2020e
Figure Pulmonary Drugs Sales Revenue (Million USD) of Actelion Pharmaceuticals, Inc. 2017-2020e
Figure Pulmonary Drugs Sales Revenue (Million USD) of Boehringer Ingelheim GmbH 2017-2020e
Figure Pulmonary Drugs Sales Revenue (Million USD) of F. Hoffmann-La Roche Ltd. 2017-2020e
Figure Pulmonary Drugs Sales Revenue (Million USD) of Merck & Co., Inc. 2017-2020e
Figure Pulmonary Drugs Sales Revenue (Million USD) of Novartis AG 2017-2020e
Figure Pulmonary Drugs Sales Revenue (Million USD) of GlaxoSmithKline plc 2017-2020e
Figure Pulmonary Drugs Sales Revenue (Million USD) of Sunovion Pharmaceuticals 2017-2020e
Executive Summary
Azoth Analytics has released a research report titled "Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition)" which provides a complete analysis of the Global IgG Mediated Autoimmune Diseases Biologic Drugs industry in terms of market segmentatio...
Executive Summary
Azoth Analytics has released a research report titled "Global Antibiotic Drugs Market (2024 Edition)" which provides a complete analysis of the global Antibiotic Drugs industry in terms of market segmentation By Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoro...
Overview of the Global Sex Hormone Drugs Market:
The report discusses everything a marketer requires before investing in the global Sex Hormone Drugs Market during the forecast period 2023-2030. It provides detailed...
Executive Summary
Azoth Analytics has released a research report titled "Incretin Based Drugs Market (2023 Edition)" which provides a complete analysis of the global Incretin Based Drugs industry in terms of market segmentation By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Di...
Overview of the Global Microecological Drugs Market :
The report discusses everything a marketer requires before investing in the global Microecological Drugs Market during the forecast period 2023-2030. It provide...
Overview of the Global Biosynthesis Peptide Drugs Market:
The report discusses everything a marketer requires before investing in the global Biosynthesis Peptide Drugs Market during the forecast period 2023-2030. It...
Overview of the Global Chemical Synthesis Peptide Drugs Market:
The report discusses everything a marketer requires before investing in the global Chemical Synthesis Peptide Drugs Market during the forecast period 2...
Description
The global veterinary dermatology drugs market exhibits positive growth prospects, forecast to expand at a CAGR of 5.4% between 2023 and 2029 to reach USD 8.08 billion in value. Veterinary dermatology focuses on treating skin diseases and disorders in animal patients, covering both...
Overview of the Global Drug Rehabilitation Drugs Market :
The report discusses everything a marketer requires before investing in the global Drug Rehabilitation Drugs Market during the forecast period 2023-2030. It...
Overview of the Global Rosuvastatin Drugs Market:
The report discusses everything a marketer requires before investing in the global Rosuvastatin Drugs Market during the forecast period 2023-2030. It provides detail...